Amy Harrington

662 total citations
19 papers, 482 citations indexed

About

Amy Harrington is a scholar working on Cellular and Molecular Neuroscience, Psychiatry and Mental health and Biological Psychiatry. According to data from OpenAlex, Amy Harrington has authored 19 papers receiving a total of 482 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cellular and Molecular Neuroscience, 6 papers in Psychiatry and Mental health and 5 papers in Biological Psychiatry. Recurrent topics in Amy Harrington's work include Tryptophan and brain disorders (5 papers), Neurotransmitter Receptor Influence on Behavior (4 papers) and Schizophrenia research and treatment (4 papers). Amy Harrington is often cited by papers focused on Tryptophan and brain disorders (5 papers), Neurotransmitter Receptor Influence on Behavior (4 papers) and Schizophrenia research and treatment (4 papers). Amy Harrington collaborates with scholars based in United States and China. Amy Harrington's co-authors include Xiaoduo Fan, Xueqin Song, Luxian Lv, Jinsong Gao, Douglas Ziedonis, Xue Li, Yang Ge, Xiujuan Wang, Jingyuan Zhao and Wei Zhang and has published in prestigious journals such as Psychopharmacology, The Annals of Thoracic Surgery and Behavioural Brain Research.

In The Last Decade

Amy Harrington

19 papers receiving 473 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amy Harrington United States 10 221 149 92 86 82 19 482
Krzysztof Kucia Poland 13 220 1.0× 114 0.8× 113 1.2× 111 1.3× 76 0.9× 44 501
Nico van Beveren Netherlands 11 239 1.1× 246 1.7× 93 1.0× 85 1.0× 58 0.7× 25 535
Guoqing Zhao China 12 208 0.9× 120 0.8× 92 1.0× 93 1.1× 41 0.5× 30 478
Yousong Su China 13 234 1.1× 146 1.0× 87 0.9× 118 1.4× 39 0.5× 40 524
Pei‐Shen Ho Taiwan 15 165 0.7× 172 1.2× 103 1.1× 59 0.7× 146 1.8× 38 584
Bianka Leitner Germany 8 204 0.9× 119 0.8× 73 0.8× 85 1.0× 34 0.4× 11 452
Ragni H. Mørch Norway 16 292 1.3× 308 2.1× 135 1.5× 161 1.9× 47 0.6× 24 741
Xinhua Shen China 16 115 0.5× 98 0.7× 81 0.9× 58 0.7× 58 0.7× 46 528
Dwight F. Newton Canada 11 89 0.4× 125 0.8× 57 0.6× 92 1.1× 45 0.5× 20 416
Arafat Hussein Al-Dujaili Iraq 12 272 1.2× 119 0.8× 142 1.5× 64 0.7× 29 0.4× 24 426

Countries citing papers authored by Amy Harrington

Since Specialization
Citations

This map shows the geographic impact of Amy Harrington's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Harrington with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Harrington more than expected).

Fields of papers citing papers by Amy Harrington

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy Harrington. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Harrington. The network helps show where Amy Harrington may publish in the future.

Co-authorship network of co-authors of Amy Harrington

This figure shows the co-authorship network connecting the top 25 collaborators of Amy Harrington. A scholar is included among the top collaborators of Amy Harrington based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy Harrington. Amy Harrington is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Brunette, Mary F., Joelle C. Ferron, Susan R. McGurk, et al.. (2019). Brief, Web-Based Interventions to Motivate Smokers With Schizophrenia: Randomized Trial. JMIR Mental Health. 7(2). e16524–e16524. 23 indexed citations
2.
Fan, Xiaoduo, Paul M. Copeland, Amy Harrington, et al.. (2019). Adjunctive telmisartan treatment on body metabolism in clozapine or olanzapine treated patients with schizophrenia: a randomized, double blind, placebo controlled trial. Psychopharmacology. 236(6). 1949–1957. 5 indexed citations
3.
Zhang, Lei, Amy Harrington, Xiaoduo Fan, et al.. (2019). Mixed methods to explore factors associated with the decline of patients in the methadone maintenance treatment program in Shanghai, China. Harm Reduction Journal. 16(1). 34–34. 3 indexed citations
4.
Lombardi, Doménico, et al.. (2019). Methamphetamine‐associated psychosis: Clinical presentation, biological basis, and treatment options. Human Psychopharmacology Clinical and Experimental. 34(5). e2710–e2710. 50 indexed citations
5.
Brown, Hannah E., Oliver Freudenreich, Xiaoduo Fan, et al.. (2019). Efficacy and Tolerability of Adjunctive Intravenous Sodium Nitroprusside Treatment for Outpatients With Schizophrenia. JAMA Psychiatry. 76(7). 691–691. 19 indexed citations
6.
Harrington, Amy, et al.. (2018). Racial disparity in mental disorder diagnosis and treatment between non-hispanic White and Asian American patients in a general hospital. Asian Journal of Psychiatry. 34. 78–83. 8 indexed citations
7.
Brunette, Mary F., Kelly A. Aschbrenner, Timothy Devitt, et al.. (2017). Characteristics and Predictors of Intention to use Cessation Treatment among Smokers with Schizophrenia: Young Adults Compared to Older Adults.. PubMed. 5(1). 8 indexed citations
8.
Harrington, Amy, et al.. (2015). Relationship between serum uric acid level and cardiometabolic risks in nondiabetic patients with schizophrenia. International Clinical Psychopharmacology. 31(1). 51–56. 3 indexed citations
9.
Du, Jiang, Meina Quan, Na Zhong, et al.. (2015). Hippocampal volume reduction in female but not male recent abstinent methamphetamine users. Behavioural Brain Research. 289. 78–83. 25 indexed citations
10.
Song, Xueqin, Xiaoduo Fan, Jianjiang Zhang, et al.. (2014). Prolactin serum levels correlate with inflammatory status in drug-naïve first-episode schizophrenia. The World Journal of Biological Psychiatry. 15(7). 546–552. 21 indexed citations
11.
Song, Xueqin, Meina Quan, Luxian Lv, et al.. (2014). Decreased cortical thickness in drug naïve first episode schizophrenia: In relation to serum levels of BDNF. Journal of Psychiatric Research. 60. 22–28. 32 indexed citations
12.
Song, Xueqin, Jingyuan Zhao, Jinsong Gao, et al.. (2014). Activation of Th17 cells in drug naïve, first episode schizophrenia. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 51. 78–82. 105 indexed citations
13.
Song, Xueqin, Xiaoduo Fan, Xue Li, et al.. (2013). Changes in pro-inflammatory cytokines and body weight during 6-month risperidone treatment in drug naïve, first-episode schizophrenia. Psychopharmacology. 231(2). 319–325. 82 indexed citations
14.
Song, Xueqin, Xiaoduo Fan, Xinwen Song, et al.. (2013). Elevated levels of adiponectin and other cytokines in drug naïve, first episode schizophrenia patients with normal weight. Schizophrenia Research. 150(1). 269–273. 64 indexed citations
15.
Cheung, Albert T., Stuart J. Weiss, Joseph S. Savino, et al.. (2003). Acute circulatory actions of intravenous amiodarone loading in cardiac surgical patients. The Annals of Thoracic Surgery. 76(2). 535–541. 18 indexed citations
16.
Rademacher, David J., et al.. (1999). The effects of amperozide on cocaine-induced social withdrawal in rats. Behavioural Brain Research. 99(1). 75–80. 7 indexed citations
17.
Steinpreis, Rhea E., et al.. (1996). The effects of raclopride on vacuous jaw movements in rats following acute administration. Physiology & Behavior. 60(1). 253–256. 3 indexed citations
18.
Harrington, Amy, et al.. (1996). The effects of cyproheptadine on vacuous jaw movements in rats: a comparison with haloperidol and clozapine.. PubMed. 32(1). 129–34. 2 indexed citations
19.
Harrington, Amy, et al.. (1996). The effects of phencyclidine and amphetamine on social behavior in tether-restrained and freely moving rats.. Experimental and Clinical Psychopharmacology. 4(1). 77–81. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Krzysztof Kucia Breakdown of academic impact, for papers by Nico van Beveren Breakdown of academic impact, for papers by Guoqing Zhao Breakdown of academic impact, for papers by Yousong Su Breakdown of academic impact, for papers by Pei‐Shen Ho Breakdown of academic impact, for papers by Bianka Leitner Breakdown of academic impact, for papers by Ragni H. Mørch Breakdown of academic impact, for papers by Xinhua Shen Breakdown of academic impact, for papers by Dwight F. Newton Breakdown of academic impact, for papers by Arafat Hussein Al-Dujaili
Rankless by CCL
2026